William Grossman has joined Arcus Biosciences (NYSE: [[ticker:RCUS]]) as chief medical officer, the same position he held at his former company, Bellicum Pharmaceuticals (NASDAQ: [[ticker:BLCM]]). Grossman’s experience also includes positions at Genentech, AbbVie (NYSE: [[ticker:ABBV]]), and Biothera. Hayward, CA-based Arcus, which raised $120 million in its IPO last year, has several cancer drugs in early-stage clinical testing.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
